Insights

Growing Market Presence Daye operates in the expanding field of women’s health technology with a substantial revenue range of 100M to 250M USD and over 75,000 users, indicating a strong market traction and potential for further expansion into digital health solutions.

Innovative Product Line With their first-in-class pain-relieving tampon and at-home infection detection tools, Daye demonstrates an innovative approach that addresses unmet needs in gynae health, offering opportunities to partner or expand product offerings.

Funding and Growth Potential Having secured 12M USD in funding, Daye is positioned for growth and scale, making it an attractive prospect for investors or business partners looking to capitalize on the women’s health tech sector.

Tech-Driven Ecosystem Leveraging advanced technology stacks like Google Cloud and data visualization tools positions Daye to develop comprehensive digital health ecosystems, opening doors for collaborations in health data analytics and remote monitoring.

Untapped Market Segments Daye’s plans to develop solutions for conditions like endometriosis, PCOS, and menopause highlight opportunities to introduce targeted health solutions or collaborate in research and development to serve underserved gynae health markets.

Daye Tech Stack

Daye uses 8 technology products and services including Power BI, Open Graph, Continuous Delivery, and more. Explore Daye's tech stack below.

  • Power BI
    Business Intelligence
  • Open Graph
    Content Management System
  • Continuous Delivery
    Continuous Integration
  • Playwright
    Frameworks And Libraries
  • TweenMax
    Javascript Frameworks
  • Microsoft
    Miscellaneous
  • PWA
    Miscellaneous
  • Cloudflare Bot Management
    Security

Media & News

Daye's Email Address Formats

Daye uses at least 1 format(s):
Daye Email FormatsExamplePercentage
First@yourdaye.comJohn@yourdaye.com
82%
First.Last@yourdaye.comJohn.Doe@yourdaye.com
18%

Frequently Asked Questions

Where is Daye's headquarters located?

Minus sign iconPlus sign icon
Daye's main headquarters is located at London, England se16 4dg United Kingdom. The company has employees across 6 continents, including EuropeNorth AmericaAsia.

What is Daye's stock symbol?

Minus sign iconPlus sign icon
Daye is a publicly traded company; the company's stock symbol is NAVODAYENT.BO.

What is Daye's official website and social media links?

Minus sign iconPlus sign icon
Daye's official website is yourdaye.com and has social profiles on LinkedInCrunchbase.

What is Daye's NAICS code?

Minus sign iconPlus sign icon
Daye's NAICS code is 92312 - Administration of Public Health Programs.

How many employees does Daye have currently?

Minus sign iconPlus sign icon
As of May 2026, Daye has approximately 110 employees across 6 continents, including EuropeNorth AmericaAsia. Key team members include Chief Operations Officer: A. P.Chief Technology Officer: E. C.Head Of Customer Care: S. D.. Explore Daye's employee directory with LeadIQ.

What industry does Daye belong to?

Minus sign iconPlus sign icon
Daye operates in the Public Health industry.

What technology does Daye use?

Minus sign iconPlus sign icon
Daye's tech stack includes Power BIOpen GraphContinuous DeliveryPlaywrightTweenMaxMicrosoftPWACloudflare Bot Management.

What is Daye's email format?

Minus sign iconPlus sign icon
Daye's email format typically follows the pattern of First@yourdaye.com. Find more Daye email formats with LeadIQ.

How much funding has Daye raised to date?

Minus sign iconPlus sign icon
As of May 2026, Daye has raised $12M in funding. The last funding round occurred on Oct 26, 2022 for $12M.

When was Daye founded?

Minus sign iconPlus sign icon
Daye was founded in 2017.

Daye

Public HealthEngland, United Kingdom51-200 Employees

Daye is a mid-sized, London, England-based startup focused on gynecological health within the public health sector. It began with the development of a tampon designed to relieve menstrual cramps, addressing a common issue for people who menstruate. After helping more than 75,000 women and AFAB individuals manage period pain, the company launched a second-generation tampon that supports at-home detection of vaginal infections, STIs, and HPV. In the next five years, Daye aims to expand into under-served gynecological conditions such as endometriosis, PCOS and menopause and build a smartphone-based health ecosystem.

Section iconCompany Overview

Headquarters
London, England se16 4dg United Kingdom
Stock Symbol
NAVODAYENT.BO
NAICS Code
92312 - Administration of Public Health Programs
Founded
2017
Employees
51-200

Section iconMedia & News

Section iconFunding & Financials

  • $12M

    Daye has raised a total of $12M of funding over 3 rounds. Their latest funding round was raised on Oct 26, 2022 in the amount of $12M.

  • $100M$250M

    Daye's revenue is estimated to be in the range of $100M$250M

Section iconFunding & Financials

  • $12M

    Daye has raised a total of $12M of funding over 3 rounds. Their latest funding round was raised on Oct 26, 2022 in the amount of $12M.

  • $100M$250M

    Daye's revenue is estimated to be in the range of $100M$250M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.